Smad7 Antisense Oligonucleotide in Crohn’s Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials
In Crohn’s disease (CD) and ulcerative colitis (UC), the major inflammatory bowel diseases (IBD) in human beings, the tissue-damaging inflammatory response is characterized by elevated levels of Suppressor of Mothers Against Decapentaplegic (Smad)7, an inhibitor of the immunosuppressive cytokine Tra...
Main Authors: | Giovanni Monteleone, Carmine Stolfi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/1/95 |
Similar Items
-
High Smad7 in the early post-operative recurrence of Crohn’s disease
by: Francesca Zorzi, et al.
Published: (2020-10-01) -
Smad7 as a positive regulator of intestinal inflammatory diseases
by: Giovanni Monteleone, et al.
Published: (2023-01-01) -
Involvement of Smad7 in Inflammatory Diseases of the Gut and Colon Cancer
by: Edoardo Troncone, et al.
Published: (2021-04-01) -
Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer
by: Edoardo Troncone, et al.
Published: (2018-06-01) -
Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer
by: Carmine Stolfi, et al.
Published: (2020-12-01)